Kei Suzuki | Profiles RNS

Kei Suzuki, MD

Assistant Professor

Boston University School of Medicine

Dept of Surgery

Cardiothoracic Surgery

MD, University of Alabama at Birmingham

Websites

Surgery Faculty

Kei Suzuki, MD, is an Assistant Professor of Surgery in Cardiothoracic Surgery at the Boston University School of Medicine. He joined the university after completing his fellowship in Thoracic Surgery at New York Presbyterian Hospital. He is licensed in Japan and America and as of last year, he is a member of the Association for Surgical Education. For his research he has received over $200,000 in funding and has been a reviewer in the following publications: Digestive Diseases and Sciences, Cancer Immunology Immunotherapy, Tumori Journal, International Editorial Board, Annals of the American Thoracic Society, Diseases of the Esophagus, and Cancer Immunology Research.

His research interests are Lung Cancer, Esophageal Cancer/Disease, and Mediastinal Disease.

2015 American Association of Thoracic Surgery: Graham Foundation Intuitive Surgical Robotics Fellowship

2011 Society of Thoracic Surgeons: Looking to the Future Scholarship

2010 Commission on Cancer Paper Competition: Finalist

2009-2011 Empire Clinical Research: Investigator Program

2008 Academic Intern of the Year

2002 Golden Key National Honor Society

2002 National Society of Collegiate Scholars

BU Sponsored Research
BMC Sponsored Research

UTILIZATION OF NASAL BIOMARKERS AS SCREENING TOOLS FOR LUNG CANCER
07/01/2018 - 06/30/2020 (PI)
Thoracic Surgery Foundation

The STABLe-mates Trial- A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotact…
12/31/2015 - 12/31/2019 (PI)
University of Texas Southwestern Med Ctr Various

Prognostic Immune Score for Stage I Lung Adenocarcinoma
09/15/2017 - 09/15/2019 (PI)
Chest Foundation

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

Yan SX, Qureshi MM, Suzuki K, Dyer M, Truong MT, Litle V, Mak KS. Definitive treatment patterns and survival in stage II non-small cell lung cancer. Lung Cancer. 2018 Oct; 124:135-142.View Related Profiles.
Suzuki, Kei
Mak, Kimberley
Dyer, Michael
Truong, Minh
Qureshi, Muhammad
Litle, Virginia
PMID: 30268452.
Gopal M, Skobodzinski AA, Sterbling HM, Rao SR, LaChapelle C, Suzuki K, Litle VR. Bronchoscopy Simulation Training as a Tool in Medical School Education. Ann Thorac Surg. 2018 Jul; 106(1):280-286.View Related Profiles.
Suzuki, Kei
Litle, Virginia
PMID: 29530773.
Muñoz-Largacha JA, Steiling KA, Kathuria H, Charlot M, Fitzgerald C, Suzuki K, Litle VR. Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital. J Thorac Cardiovasc Surg. 2018 Jun; 155(6):2674-2681.View Related Profiles.
Kathuria, Hasmeena
Steiling, Katrina
Suzuki, Kei
Charlot, Marjory
Litle, Virginia
PMID: 29534906.
Muñoz-Largacha JA, Slama J, Kalish J, Jalisi S, Litle VR, Suzuki K. Approach to resection of sternoclavicular tumor abutting the common carotid artery in irradiated field. J Thorac Dis. 2018 Jan; 10(1):E38-E41.View Related Profiles.
Kalish, Jeffrey
Suzuki, Kei
Litle, Virginia
PMID: 29600101.
Billè A, Ahmad U, Woo KM, Suzuki K, Adusumilli P, Huang J, Jones DR, Rizk NP. Detection of Recurrence Patterns After Wedge Resection for Early Stage Lung Cancer: Rationale for Radiologic Follow-Up. Ann Thorac Surg. 2016 Oct; 102(4):1067-73. PMID: 27345095; DOI: 10.1016/j.athoracsur.2016.04.056;.
Ripley RT, Suzuki K, Tan KS, Adusumilli PS, Huang J, Park BJ, Downey RJ, Rizk NP, Rusch VW, Bains M, Jones DR. Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):969-77, 979.e1-3. PMID: 26614420; PMCID: PMC4801676; DOI: 10.1016/j.jtcvs.2015.09.127;.
Suzuki K, Park BJ, Adusumilli PS, Rizk NP, Huang J, Jones DR, Bains MS. Chest Wall Reconstruction Using a Methyl Methacrylate Neo-Rib and Mesh. Ann Thorac Surg. 2015 Aug; 100(2):744-7. PMID: 26234861; PMCID: PMC4978354; DOI: 10.1016/j.athoracsur.2015.02.127;.
Ahmad U, Yang H, Sima C, Buitrago DH, Ripley RT, Suzuki K, Bains MS, Rizk NP, Rusch VW, Huang J, Adusumilli PS, Rocco G, Jones DR. Resection of Primary and Secondary Tumors of the Sternum: An Analysis of Prognostic Variables. Ann Thorac Surg. 2015 Jul; 100(1):215-21; discussion 221-2. PMID: 26002443; PMCID: PMC4634707; DOI: 10.1016/j.athoracsur.2015.03.013;.
Suzuki K, Bower M, Cassaro S, Patel RI, Karpeh MS, Leitman IM. Tube cholecystostomy before cholecystectomy for the treatment of acute cholecystitis. JSLS. 2015 Jan-Mar; 19(1):e2014.00200. PMID: 25848180; PMCID: PMC4376213; DOI: 10.4293/JSLS.2014.00200;.
Suzuki K, Sieczka E, Tranbaugh R, Hoffman D. Pyoderma gangrenosum after cardiac surgery masquerading as a fulminant sternal wound infection. Int J Surg Case Rep. 2015; 6C:163-5. PMID: 25544482; PMCID: PMC4337912; DOI: 10.1016/j.ijscr.2014.06.010;.

Showing 10 of 26 results. Show More

Kachala SS, Bograd AJ, Villena-Vargas J, Suzuki K, Servais EL, Kadota K, Chou J, Sima CS, Vertes E, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma. Clin Cancer Res. 2014 Feb 15; 20(4):1020-8. PMID: 24334761; PMCID: PMC3944669; DOI: 10.1158/1078-0432.CCR-13-1862;.
Leitman IM, Suzuki K, Wengrofsky AJ, Menashe E, Poplawski M, Woo KM, Geller CM, Lucido D, Bernik T, Zeifer BA, Patton B. Early recognition of acute thoracic aortic dissection and aneurysm. World J Emerg Surg. 2013 Nov 13; 8(1):47. PMID: 24499618; PMCID: PMC3874654; DOI: 10.1186/1749-7922-8-47;.
Suzuki K, Miyamoto M, Miyamoto T, Suzuki S, Watanabe Y, Numao A, Iwanami M, Tatsumoto M, Sada T, Kadowaki T, Hashimoto K, Sakuta H, Hirata K. Snoring is associated with an impaired motor function, disease severity and the quality of life but not with excessive daytime sleepiness in patients with Parkinson's disease. Intern Med. 2013; 52(8):863-9. PMID: 23583989.
Suzuki K, Kadota K, Sima CS, Nitadori J, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor ß2 (IL-12Rß2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol. 2013 Feb 01; 31(4):490-8. PMID: 23269987; PMCID: PMC3731922; DOI: 10.1200/JCO.2012.45.2052;.
Kadota K, Kachala SS, Nitadori J, Suzuki K, Dunphy MP, Sima CS, Travis WD, Rusch VW, Adusumilli PS. High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology. J Thorac Oncol. 2012 Jul; 7(7):1192-7. PMID: 22617244; PMCID: PMC3691682; DOI: 10.1097/JTO.0b013e3182519d96;.
Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma. Ann Surg Oncol. 2012 Oct; 19(11):3598-605. PMID: 22644511; PMCID: PMC4049004; DOI: 10.1245/s10434-012-2414-3;.
Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol. 2012 Aug; 25(8):1117-27. PMID: 22499226; PMCID: PMC4382749; DOI: 10.1038/modpathol.2012.58;.
Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS. An in vivo platform for tumor biomarker assessment. PLoS One. 2011; 6(10):e26722. PMID: 22046338; PMCID: PMC3202552; DOI: 10.1371/journal.pone.0026722;.
Kadota K, Suzuki K, Colovos C, Sima CS, Rusch VW, Travis WD, Adusumilli PS. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma. Mod Pathol. 2012 Feb; 25(2):260-71. PMID: 21983936; PMCID: PMC4080411; DOI: 10.1038/modpathol.2011.146;.
Bograd AJ, Suzuki K, Vertes E, Colovos C, Morales EA, Sadelain M, Adusumilli PS. Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma. Cancer Immunol Immunother. 2011 Nov; 60(11):1509-27. PMID: 21913025; PMCID: PMC3268654; DOI: 10.1007/s00262-011-1103-6;.
Suzuki K, Kadota K, Sima CS, Sadelain M, Rusch VW, Travis WD, Adusumilli PS. Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients. Cancer Immunol Immunother. 2011 Dec; 60(12):1721-8. PMID: 21769693; DOI: 10.1007/s00262-011-1073-8;.
Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, Rusch VW, Travis WD, Adusumilli PS. Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res. 2011 Aug 15; 17(16):5247-56. PMID: 21659461; DOI: 10.1158/1078-0432.CCR-10-2805;.
Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thorac Oncol. 2011 May; 6(5):896-904. PMID: 21358344; DOI: 10.1097/JTO.0b013e318211127a;.
Suzuki K, Servais EL, Rizk NP, Solomon SB, Sima CS, Park BJ, Kachala SS, Zlobinsky M, Rusch VW, Adusumilli PS. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters. J Thorac Oncol. 2011 Apr; 6(4):762-7. PMID: 21325982; DOI: 10.1097/JTO.0b013e31820d614f;.
Yushuva A, Nagda P, Suzuki K, Llaguna OH, Avgerinos D, Goodman E. Heterotopic mesenteric ossification following gastric bypass surgery: case series and review of literature. Obes Surg. 2010 Sep; 20(9):1312-5. PMID: 20127291; DOI: 10.1007/s11695-009-0072-8;.
Colovos C, Suzuki K, Leitman IM, Adusumilli PS. Surgeons and simulators. Natl Med J India. 2009 Nov-Dec; 22(6):323-4. PMID: 20384025.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 26 publications over 9 distinct years, with a maximum of 7 publications in 2011